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Abstract: A 4-year hospital-based survey was conducted in Rio de Janeiro to determine baseline rates of gastroenteritis-
related cases, hospitalizations, and deaths; to examine the prevalence of rotavirus strains causing admissions; and to assess 
the immediate impact of the nationwide rotavirus immunization program launched in March 2006. From August 2002 to 
May 2007, 14,473 (10.4%) of the 139,747 consultations had AGE as primary diagnosis, 491 (3.4%) children required 
hospitalization and two (0.4%) dehydrated children died. Gastroenteritis contribution to hospitalizations varied from 
~2.3% in 2004 and 2006 to 6.4% in 2005, being roughly half of them rotavirus-related cases. A gradual decrease in 
rotavirus strain diversity was observed from 2002 to 2005 when a single G9P[8] prevailed until April 2006. Then only 
short profile G9P[4] and G2P[4] strains were detected. Gastroenteritis cases were distributed year-round in a trimodal 
pattern with major winter peaks. Local climate apparently affected the incidence of gastroenteritis: reduction in dry years 
(2004 and 2007) and explosive outbreaks caused by multiple agents during the heavy rainfalls and recurrent floods of the 
2005-early 2006 period. Besides rotavirus, adenovirus and calicivirus were major gastroenteritis agents of these seemingly 
waterborne outbreaks. In conclusion, rotavirus vaccination impacted marginally, if at all, on the incidence of childhood 
gastroenteritis, as favorable results obtained by comparing data from the post-vaccine period to the preceding unusual 
2005 year all but disappeared when comparing to previous pre-vaccination periods, and the shift towards G2P[4] rotavirus 
strains may be a global trend unrelated to vaccination. 
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INTRODUCTION 
  Acute gastroenteritis (AGE) is a major global problem, 
particularly in infants and children less than 4 years of age 
living in developing countries [1]. Major pathogens include 
bacteria, enteric parasites and viruses, among which, 
rotavirus is considered the major cause of severe diarrhea 
leading to dehydration, hospital admissions, and significant 
medical and societal costs [2]. Precise estimates of rotavirus-
related morbidity and mortality in Brazil are not available 
because viral testing is not performed routinely in specimens 
from children with diarrhea, either hospitalized or non-
hospitalized, and test results from private clinics are not 
included in the unified health system (DATASUS). By using 
generalized linear models, a time series analysis of the 
mortality and morbidity patterns of severe diarrhea 
(hospitalizations) in children <5 years old in Rio de Janeiro 
from 1995 to 1998, showed winter seasonality and annual 
cycles that suggested the predominance of rotavirus as the 
main pathogen [3]. Those results were consistent with 
studies on the etiologic agents of diarrhea conducted in 
several parts of the country [4]. Based on public 
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health considerations, the decision was made to recommend 
rotavirus vaccine to prevent and control severe diarrhea in 
Brazil. The chosen vaccine was an attenuated human 
rotavirus (Rotarix, GSK, Belgium) extensively tested in 
clinical trials in several Latin American countries [5, 6]. In 
Brazil, this monovalent G1P[8] rotavirus vaccine was 
licensed and became available in private pediatric clinics in 
August 2005, and by March 2006, it was incorporated into 
the National Childhood Immunization Program of the 
Brazilian Public Health System (SUS) providing 
countrywide free vaccination to all children at 2 and 4 
months of age for the recommended two-dose regimen, 
respectively. 
  The present work aimed at determining baseline rates of 
AGE cases, AGE-related hospitalizations and deaths in a 
sentinel hospital in Rio de Janeiro, to estimate the proportion 
of those cases caused by rotavirus infection, and to assess 
any immediate impact of the rotavirus immunization 
program on childhood diarrhea. 
MATERIALS AND METHODOLOGY 
  The survey was conducted at the emergency of the 
Instituto de Pediatria e Puericultura Martagão Gesteira 
(IPPMG), beginning after approval by its Ethical Committee 
(Proc.#08/2002) in August 2002 and ending in May 2007, 
when the service was closed for building repairs. The 
hospital is located at the university’s main campus near 
major expressways leading from downtown Rio de Janeiro to 
its lowland outskirts (Baixada Fluminense). It serves the low Pediatric Diarrhea Before and After Rotavirus Vaccine Program in Brazil  The Open Virology Journal, 2009, Volume 3    27 
socio economic population of a nearby huge conglomerate of  
 
over 20 communities established during the last two decades. 
Due to lack of a computerized information system, data were 
gathered from medical bulletins and patient records. Parents 
of children admitted for rehydration therapy were invited to 
participate in the study providing the child’s fecal specimen 
for viral testing. 
  Results on rotavirus detection and typing have been 
published [7]. Adenovirus was detected by an enzyme 
immunoassay kindly supplied by Biomanguinhos, Fiocruz, 
Brazil. Vital statistics and rotavirus immunization data were  
obtained from the Municipality of Rio de Janeiro   
(www.rio.rj.gov.br) and from DATASUS, Ministry of 
Health of Brazil (www.datasus.gov.br). 
RESULTS 
  A total of 139,747 consultations were recorded at the 
emergency service during the consecutive 58-month study 
period: 14,473 (10.4%) had AGE as primary diagnosis and 
491 (3.4%) of those cases were admitted for rehydration 
therapy (Table 1). Monthly AGE cases varied from 102 to 
528 (mean 250) within the 1528 to 3066 (mean 2410) 
monthly visits at the service for all medical causes. Apart 
from the incomplete years of 2002 and 2007, the yearly 
contribution of AGE to hospital admissions varied from 
~2.3% in 2004 and 2006 to 6.4% in 2005, resulting in an 
overall mean of 3.5% of all registered hospitalizations. The 
temporal distribution of AGE cases and AGE-related 
hospitalizations showed a cyclic pattern with annual peak 
prevalence in winter, but great year-to-year variations in the 
number of other peaks, their amplitude, and month of 
occurrence (Fig. 1). The winter peak, usually associated with 
rotavirus diarrhea, was present in all four complete years of 
study and occurred in June 2003, 2004 and 2005 and in May 
2006. Secondary early autumn peaks in March, also 
associated with rotavirus, and thirdly late peaks in October, 
not associated with rotavirus, were generally present. The 
atypical year of 2005 showed the highest prevalence of AGE 
cases, with peaks that occurred throughout the year and 
proceeded until the mid-winter of 2006, declining afterwards 
to the usual low summer level. This abnormally high number 
of AGE cases, diagnosed at all seasons from January 2005 to 
July 2006, most likely reflected the occurrence of multiple 
outbreaks involving distinct etiological agents as discussed 
below. 
  Although the yearly numbers of AGE-related admissions 
were small, their winter annual peaks coincided with the 
Table 1.  Number of Emergency Visits, AGE Cases and AGE-Related Hospitalizations at IPPMG During the 58 Months Study 
Period from August 2002 to May 2007. 
 
Consultations (%)  Hospitalizations (%) 
Year 
All Causes  AGE Cases  All Causes  AGE-Related  % of AGE Cases 
2002*  13501  1068 (7.9)  1050  33 (3.1)  3.1 
2003  29773  2786 (9.4)  2853  109 (3.8)  4.0 
2004  28440  2413 (8.5)  2822  67 (2.4)  2.8 
2005  30978  4230 (13.6)  3185  203 (6.4)  4.8 
2006  28214  3266 (11.6)  2943  66 (2.2)  2.0 
2007*  8841  710 (8.8)  1100  13 (1.2)  1.8 
Total  139747  14473 (10.4)  13953  491 (3.5)  3.4 
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major AGE prevalence peaks (Figs. 1,  2). Overall, 193   
(~ 40%) of the 491 hospitalized children were enrolled 
providing specimens for analysis. Rotavirus was found 
associated with 96 (50%) of the severe diarrhea cases (Fig. 
2). Their electropherotypes and GP genotypes were reported 
previously [7]. Great diversity of strains of distinct 
genotypes and frequent mixtures of strains were found 
during the first three years, with the predominant genotype 
gradually shifting from G1P[8] in 2002 to G9P[8] in 2004, 
preceding a very unusual 2005 season in which a single 
G9P[8] strain accounted for all the severe rotavirus-
associated cases. Another change in rotavirus strains causing 
hospitalization was observed in April of 2006 when the 
common long profile, P[8] strains were abruptly replaced by 
short electropherotypes of P[4] specificity, mainly G9P[4] 
and G2P[4] strains (Fig. 2) [7]. None of the children infected 
with a short profile strain was eligible for rotavirus 
vaccination. On the other hand, one child, out of the four 
hospitalized children eligible for vaccination in 2006, 
presented severe rotavirus infection: strain G9P[8], the last 
long profile detected in April 2006, was recovered from this 
3-month old male child’s specimen who had received the 
first vaccine dose two weeks before onset of illness. From 
January to May 2007, five vaccinated children were 
hospitalized due to AGE but specimens were not collected. 
Group C rotavirus was diagnosed in a single severe diarrhea 
case in July 2003, giving an overall 0.5% prevalence. 
Adenovirus was detected in a child’s specimen by the end of 
December 2004. Afterwards, five more adenovirus-related 
cases were found dispersed throughout the following year, 
accounting for the high annual rate of 7.5% adenovirus-
related admissions and an overall 3.1% prevalence during the 
58-month study period. 
  In general, children in the 12 to 35-month old group 
accounted for the highest proportion of both AGE cases 
(34.4%) and AGE-related admissions (39.1%) at IPPMG, but 
the chance of requiring hospitalization due to dehydrating 
diarrhea was inversely proportional to the child’s age, with 
infants less than 6-month old having about twice the chance 
of requiring rapid intravenous fluid replacement than older 
infants (Table 2). Four infants < 2-month old were 
hospitalized due to AGE (in June 2003, March, April and 
September 2005), but none were enrolled for viral testing. 
The male:female rate of hospitalized children was 1.2 
(54.4% male and 45.6% female) with a slight predominance 
of male children hospitalized at all years except 2006. 
  There were two AGE-related deaths recorded during the 
study period: both fatality cases were severely dehydrated 8 
and 6 months old male infants admitted in January 2003 and 
May 2006. Specimens were not collected and details will be 
published elsewhere. 
DISCUSSION 
  This single hospital-based survey spanned almost 5 years 
and demonstrated that a tenth of the emergency consultations 
had AGE as the primary diagnosis and that only a small 
proportion of those (3.4%) required hospitalization. Overall, 
AGE contributed with 3.5% of the hospitalizations for all 
medical causes, and rotavirus contributed with roughly half 
(1.75%) of those hospital admissions. However, the 
epidemiology of both AGE and rotavirus-related 
hospitalizations showed significant year-to-year variation. 
Among the factors that influence spread and transmission of 
 
Fig. (2). Distribution of AGE-related and rotavirus-related hospitalizations at IPPMG from August 2002 to December 2006. 
Table 2.   Distribution and Prevalence of AGE-Related Cases, AGE-Related Hospitalizations, and Rotavirus-Related Admissions at 
IPPMG by Age Group 
 
Age Group (Months)   
< 6  6 - 11  12 -35  36 - 60  > 60 
AGE cases (%)  693 (4.8)  2361 (16.3)  4973 (34.4)  3429 (23.7)  3017 (20.8) 
Hospitalizations (%)  49 (10.0)  101 (20.6)  192 (39.1)  84 (17.1)  65 (13.2) 
%Admission rate   7.0  4.3  3.9  2.5  2.2 
Rotavirus positive/analysed  18/34  31/50  37/76  7/24  3/9 
% Rotavirus rate*  53  62  49  29  33 
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gastroenteritis agents is local climate. Rio de Janeiro has a 
subtropical climate with monthly mean temperatures ranging 
from 17-20
oC in the usually dry winter months (June-
August) to 32-35
oC in the summer months (December-
February) with intermittent rainy periods from November to 
March. Unusual phenomena occurred in the city during the 
study period: a prolonged drought during 2004 was followed 
by an extremely wet year (2005) that begun with heavy 
rainfalls and repeated floods. Interestingly, the dry year of 
2004 showed reduced AGE-related cases, though not 
rotavirus-related cases; whereas the extended rainy period of 
2005-early 2006 coincided with an increased frequency of 
AGE cases during the entire period and a change in the 
pattern of rotavirus strains causing severe disease. The high 
diversity of rotavirus strains associated with hospitalizations 
observed up to 2004 in this and in other studies, which 
putatively represents the heterogeneous pool of endemic 
strains circulating in the community, was replaced by an 
unprecedented lack of diversity in rotavirus strains causing 
severe AGE in children in 2005. This seems typical of an 
epidemic outbreak caused either by the introduction of a 
novel rotavirus serotype in the community or spread by less 
common means of rotavirus transmission, such as 
waterborne [8, 9]. But rotavirus G9P[8] was not new in the 
city: the mid-1990s genotype G9 pandemic struck Brazil in 
1996 and G9P[8] strains have been detected since in many 
cities with fluctuating frequencies, as expected for any 
rotavirus serotype [10-13]. Furthermore, the atypical 2005 
season showed a lower rotavirus detection rate (34%) than 
those of the previous or following years (55-86%) despite 
predominance of an epidemic strain: the characteristic 
bimodal yearly distribution of rotavirus-related cases and 
admissions was surmounted by peaks of non-rotavirus ones, 
clearly demonstrating the concurrence of outbreaks caused 
by other AGE agents, and further supporting a common, 
waterborne, source. Adenovirus, which has been implicated 
in 0-5% of AGE-related hospitalizations worldwide, was 
associated with >7% of the 2005 admissions. The presence 
of caliciviruses and astroviruses in the collected specimens 
are currently being investigated, but preliminary results seem 
to indicate that norovirus (the most common human 
calicivirus) played a significant role in the 2005-early 2006 
AGE cases in children as part of the major epidemic that 
swept the coastal area of Brazil in the autumn of 2005. 
Although affecting all age groups, it was extensively 
reported in the news media and perceived by many as a new 
rotavirus threat. Similar epidemic outbreaks occurred the 
following year when norovirus GII.4 was predominantly 
detected in the general population of Salvador, Bahia, and in 
young children hospitalized in Vitória, Espírito Santo [14, 
15]. Although calicivirus infections have been traditionally 
associated to food or waterborne outbreaks of mild to 
moderate AGE in adults, they were relatively common (33% 
prevalence) among young children with or without AGE in a 
study in São Paulo, Brazil, and have been increasingly 
implicated in severe cases requiring hospitalization of 
European children during periods of AGE epidemics [16, 
17]. AGE outbreaks caused by caliciviruses have been well 
documented in cruise ships [18, 19]. As short cruises along 
the Brazilian coast aboard American or European ships are 
becoming  
 
increasingly affordable to middle-class Brazilians and 
astonishing popular during summer vacation and carnival 
since 2003 (1,000% increase in number of passengers), year-
round AGE outbreaks affecting all age groups apparently 
have followed the trend [20]. Thus, calicivirus should be 
considered a likely cause of hospitalization due to 
dehydration among young children in tourist resorts and 
major ports. 
  With an estimated cohort of 87,222 live births, rotavirus 
immunization program in the city of Rio de Janeiro (~6 
million inhabitants) achieved 43% full coverage (2 doses) in 
2006 and 72% in 2007. This result is above the average 
coverage for the state of Rio de Janeiro (38% and 45%) and 
for Brazil (39% and 46%) in 2006 and 2007, respectively. 
By taking into account those infants that received a single 
vaccine dose, it may be possible to assume that 76-88% of 
the newborns were exposed to the vaccine virus, inducing a 
herd immunity effect and protecting children in the 
community against severe disease caused by strains 
serologically related to the vaccine virus (G1 or P[8]), but 
not against serologically unrelated strains such as G2P[4] 
and G9P[4] [5, 6]. This may explain the lack of detection of 
previously endemic strains during the first year post-
vaccination. Although no epidemic outbreak of G2P[4] 
rotavirus-related AGE has yet occurred in Brazil, the 
program faces the challenge of an apparent trend towards its 
global reemergence, as observed in countries that have not 
introduced a rotavirus vaccine [21, 22]. 
CONCLUSION 
  Similar to a study in Panama City [23], no major impact 
that could be definitely linked to the introduction of the 
rotavirus vaccine was found thus far: the significant 
reduction in AGE cases and hospitalizations observed in 
post-vaccination 2006-early 2007 period when compared to 
the unusual 2005 year practically disappeared when 
compared to those observed in the usual pre-vaccination 
years of 2003-2004; the April 2006 shift in rotavirus 
genotypes causing severe disease in children may reflect the 
spontaneous fluctuation in the prevalence of rotavirus 
genotypes seen anywhere in pre-vaccination times and may 
be marginally associated to the vaccination program. 
Nevertheless, this study demonstrated that any attempt to 
estimate the impact of the program needs to take into 
consideration local epidemiological features and natural 
trends of rotavirus disease, as well as environmental 
conditions and new behavioral tendencies, such as the 
“cruise ship fever” that overtook middle-class tourism 
worldwide resulting in the explosive global spread of 
norovirus GII4 strains [24]. 
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